Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11161819 | Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists | Gregory L. Adams, Jason M. Cox, John S. Debenham, Scott D. Edmondson, Eric J. Gilbert +15 more | 2021-11-02 |
| 9708270 | Substituted spiropiperidinyl compounds useful as GPR120 agonists | Mariappan V. Chelliah, Hong Dong Chu, Jason M. Cox, John S. Debenham, Keith Eagen +7 more | 2017-07-18 |
| 9328138 | HCV NS3 protease inhibitors | Michael T. Rudd, John A. McCauley, Nigel J. Liverton, Christiane Grisé-Bard, Marie-Christine Brochu +12 more | 2016-05-03 |
| 8987195 | HCV NS3 protease inhibitors | Thomas Bara, Sathesh Bhat, Dipshikha Biswas, Linda Brockunier, Duane A. Burnett +17 more | 2015-03-24 |
| 8987242 | Morpholinone compounds as factor IXA inhibitors | Samuel Chackalamannil, Tin-Yau Chan, Mariappan V. Chelliah, Martin C. Clasby, Michael P. Dwyer +6 more | 2015-03-24 |
| 8604195 | Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1 | Craig D. Boyle, Samuel Chackalamannil | 2013-12-10 |
| 8580807 | Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders | Craig D. Boyle, Claire M. Lankin, William J. Greenlee, Samuel Chackalamannil | 2013-11-12 |
| 8466149 | 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I | Craig D. Boyle, Samuel Chackalamannil, Claire M. Lankin | 2013-06-18 |
| 8389532 | 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine | Craig D. Boyle, Samuel Chackalamannil, Jean E. Lachowicz | 2013-03-05 |
| 8318751 | Pyrimidinone derivatives and methods of use thereof | Craig D. Boyle, Samuel Chackalamannil, Claire M. Lankin, Bernard R. Neustadt, Hong Liu +1 more | 2012-11-27 |
| 7709492 | Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists | Bernard R. Neustadt, Jinsong Hao, Hong Liu, Craig D. Boyle, Samuel Chackalamannil +2 more | 2010-05-04 |
| 7572802 | 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine | Craig D. Boyle, Samuel Chackalamannil, Jean E. Lachowicz | 2009-08-11 |
| 7465740 | 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists | Bernard R. Neustadt, Craig D. Boyle, Samuel Chackalamannil, Joel M. Harris, Claire M. Lankin +2 more | 2008-12-16 |
| 7368449 | 2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists | Bernard R. Neustadt, Jinsong Hao, Hong Liu, Craig D. Boyle, Samuel Chackalamannil +1 more | 2008-05-06 |
| 6916811 | Adenosine A2a receptor antagonists | Craig D. Boyle, Samuel Chackalamannil, William J. Greenlee, Yan Xia | 2005-07-12 |
| 6897217 | 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists | Bernard R. Neustadt, Jinsong Hao, Hong Liu, Craig D. Boyle, Samuel Chackalamannil +1 more | 2005-05-24 |